X hits on this document





7 / 7


  • 19.

    Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W. 2001. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol. Psychiatry. 49: 333-339.

  • 20.

    Cheuk DK, Li SY, Wong V. 2006. No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141: 123-125.

  • 21.

    Qian Q, Wang Y, Zhou R, Yang L, Faraone SV. 2004. Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 128: 84-89.

  • 22.

    Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL,Harrington R, McGuffin P, Owen M, Ollier W, Worthington J, Thapar A. 2000. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol. Psychiatry. 5: 523-530.

  • 23.

    Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52: 506-516.

  • 24.

    Waldman ID, Robinson BF, Feigon SA. 1997. Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity. Genet. Epidemiol. 14: 699-704.

  • 25.

    Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR.

    • 1992.

      Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and

displays a VNTR. Genomics. 14: 1104-1106.

  • 26.

    Jaber M, Jones S, Giros B, Caron MG. 1997. The dopamine transporter: a crucial component regulating dopamine transmission. Mov. Disord. 12: 629-633.

  • 27.

    Nakamura Y, Koyama K, Matsushima M. 1998. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J. Hum. Genet. 43: 149-152.

  • 28.

    Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. 1997. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol. Psychiatry. 2: 311-313.

  • 29.

    Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry. 4: 192-196.

  • 30.

    Mitchell RJ, Howlett S, Earl L, White NG, McComb J, Schanfield MS, BricenoI, Papiha SS, Osipova L, Livshits G, Leonard WR, Crawford MH. 2000. Distribution of the 3'VNTR polymorphism in the human dopamine transporter gene in world populations. Hum. Biol. 72: 295-304.

  • 31.

    Kang AM, Palmatier MA, Kidd KK. 1999. Global variation of a 40-bp VNTR in the 3'- untranslated region of the dopamine transporter gene (SLC6A3). Biol. Psychiatry. 46: 151-160.

  • 32.

    Daley D. 2006. Attention deficit hyperactivity disorder: a review of the essential facts. Child Care Health Dev. 32: 193-204.

  • 33.

    Sonuga-Barke EJ, Sergeant J. 2005. The neuroscience of ADHD: multidisciplinary perspectives on a complex developmental disorder. Dev. Sci. 8: 103-104.


Document info
Document views29
Page views29
Page last viewedMon Jan 23 02:33:35 UTC 2017